Vancomycin-Associated Leukocytoclastic Vasculitis

الملخص EN

Vancomycin is U.S.

Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics.

Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published.

We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin.

Skin biopsy revealed leukocytoclastic vasculitis.